WASHINGTON — A senior Food and Drug Administration official who played a pivotal role in the agency’s controversial handling of the diabetes pill Rezulin has resigned his post and temporarily assumed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback